U.S. Gas Utilities Stock News

Travere Therapeutics (TVTX) stock is in focus after the company reported its first non-GAAP profitable quarter, coinciding with long term FILSPARI data from the Phase 3 DUPLEX Study in focal segmental glomerulosclerosis. See our latest analysis for Travere Therapeutics. The recent 1-day share price return of 6.4% to US$52.04 caps a sharp run, with a 90-day share price return of 85.66% and a 1-year total shareholder return of roughly 3.6x. This suggests momentum is building as the market...

Miller Electric, a subsidiary of Illinois Tool Works, recently expanded its Copilot robotic welding family with Copilot Builder featuring a FANUC CRX-130 cobot and a Copilot version configured with the XR-AlumaPro CB torch, aiming to simplify larger and aluminum welding applications. This push into more accessible robotic welding automation highlights Illinois Tool Works' emphasis on customer-focused innovation in industrial automation and advanced manufacturing workflows. We’ll now examine...

Oruka Therapeutics (ORKA) stock has drawn attention after a strong run over the past year, with the share price last closing at $69.89 and market value around $4.2b. See our latest analysis for Oruka Therapeutics. The recent move to $69.89 caps a strong run, with the share price return of 147.22% year to date and a 1 year total shareholder return of about 4.6x pointing to strong momentum rather than a short term spike. If you are looking beyond Oruka Therapeutics, this could be a good moment...

In June 2026, Insight Enterprises amended its asset-based lending facility with JPMorgan Chase to add a US$100 million swingline sub-facility, while also launching Insight Managed Exposure Defense, a bundled managed security service designed to help organizations respond to fast-emerging AI-driven cyber vulnerabilities across infrastructure, applications, and software supply chains. The combined moves highlight Insight’s push to deepen its role in AI-centric cybersecurity while bolstering...

Recent performance context for Hope Bancorp Hope Bancorp (HOPE) has drawn attention after a period of solid share price performance, with the stock up about 11% over the past month and 22% over the past 3 months. See our latest analysis for Hope Bancorp. Looking beyond the recent bounce, Hope Bancorp’s 1 year total shareholder return of 36.88% and 3 year total shareholder return of 73.14% sit alongside a 5 year total shareholder return of 19.95%. This suggests momentum has been stronger in...

Recent performance snapshot MaxLinear (MXL) has seen mixed share price moves, with a gain of about 4.2% over the past week and a decline of roughly 8.5% over the past month, leaving the stock near US$84.46. See our latest analysis for MaxLinear. That recent 4.2% one-day share price move comes after a choppy month, with the share price down about 8.5% over 30 days but supported by very strong 90-day and 1-year total shareholder returns. This suggests momentum has been building over a longer...

BKV (BKV) is on investors’ radar after an eventful stretch that combined annual meeting decisions, a revised lending agreement that affects financial flexibility, and a reaffirmed bullish analyst stance paired with a more cautious short term view. See our latest analysis for BKV. BKV’s share price has softened recently, with a 30 day share price return down 12.1% and a year to date share price return down 8.7%. However, the 1 year total shareholder return is 7.5%. This suggests momentum has...

Marsh & McLennan Companies recently entered into an amended and restated five-year multi-currency unsecured revolving credit agreement for US$4.25 billion, replacing its prior US$3.50 billion facility and extending access to liquidity through June 2031 under covenants tied to coverage and leverage ratios. This larger revolving credit facility, with pricing linked to Term SOFR and the company’s credit ratings, provides added financial flexibility that can support future capital allocation...

KKR (KKR) is back in focus after unveiling Helix Digital Infrastructure, a new AI-focused platform with more than US$10 billion in long-term capital commitments. It was launched alongside NVIDIA, Vistra and the Kuwait Investment Authority. See our latest analysis for KKR. The Helix announcement comes after an active few weeks for KKR, including fresh bids for Irish energy distributor DCC and a new equity investment in advisory firm Crowe. This comes alongside a share price of US$96.24 that...

Earlier this week, Barclays reiterated its Equal Weight rating on Range Resources while updating its outlook to reflect tighter global oil market conditions and a softer near-term gas price view due to oversupply. The bank’s commentary links shrinking oil inventories, reduced OPEC spare capacity, and geopolitical risks to a potential re-rating for exploration and production companies such as Range Resources once regional tensions ease. We’ll now explore how Barclays’ emphasis on tighter oil...

PPL Electric Utilities has received approval from the Pennsylvania Public Utility Commission for new distribution rates, effective July 1, 2026, which are expected to lift its annual revenues by US$275,000,000 to support grid modernization, smart-grid technologies, and infrastructure upgrades. This regulatory decision is important because it underpins PPL’s stated 6–8% annual earnings growth target through 2029 by enhancing revenue visibility for its planned capital program. Next, we’ll...

Axcelis Technologies (ACLS) is back on traders’ screens after a sector wide rally in semiconductor equipment stocks, as renewed interest in chip manufacturing demand and capital spending lifted the shares. See our latest analysis for Axcelis Technologies. The recent 7 day share price return of 22.4%, on top of a 90 day share price return of 113.03%, points to strong momentum building after the sector wide rally. Over the longer term, the 1 year total shareholder return of 176.81% compared...

Dauch (DCH) is back in focus after reaching a tentative contract agreement with UAW Local 2093 at its Three Rivers, Michigan facility, following a work stoppage that began on June 1, 2026. See our latest analysis for Dauch. At a share price of $6.35, Dauch has posted a 16.94% 90 day share price return, while the 1 year total shareholder return of 53.38% contrasts with weaker 3 and 5 year total shareholder returns. This suggests that recent momentum follows a tougher longer term stretch. If...

Assurant (AIZ) is back on investors’ radar after being chosen by Owen to provide insurance capacity for Swan’s next generation card offering, embedding travel cover and fraud protection into B2B SaaS payment flows across Europe. See our latest analysis for Assurant. The recent Owen and Swan partnership sits against a backdrop of firm momentum, with Assurant’s share price delivering a 17.48% 90 day return and a 9.79% year to date return, while its 1 year total shareholder return stands at...

Debt offering sets the stage for fresh investor questions Cheniere Energy Partners (CQP) has completed a private placement of US$1.75b in senior notes, a financing move that puts its capital structure and long term obligations back in focus for income oriented investors. See our latest analysis for Cheniere Energy Partners. The debt offering comes after a mixed stretch for the stock, with the share price down 3.81% over the last day but still showing a 17.02% year to date share price return...

In recent days, Origin Bancorp received an analyst upgrade to a more favorable rating, reflecting growing optimism about its earnings outlook based on rising estimates. This shift in sentiment comes despite the bank’s historically modest revenue and earnings-per-share progress, highlighting a tension between short-term optimism and longer-term performance trends. Next, we’ll examine how this earnings-driven analyst upgrade interacts with Origin Bancorp’s existing growth, efficiency, and...

Earlier this month, HP Inc. unveiled the HP Limited Edition Scuderia Ferrari AI PC, a serialized US$5,599 collector device limited to 4,999 units, alongside a broader lineup of new AI-focused notebooks, desktops, and developer systems. The Ferrari collaboration and RTX Spark-powered developer PCs underscore HP’s push into premium and AI-centric computing, aiming to appeal to enthusiasts, creators, and enterprise AI developers alike. We’ll now examine how HP’s Ferrari-branded AI PC and...

Belite Bio recently completed the rolling submission of its New Drug Application to the U.S. FDA for tinlarebant, an investigational oral therapy for Stargardt disease type 1 that has received multiple expedited designations and follows a Phase 3 trial meeting its primary endpoint. This filing marks a critical step toward potential FDA acceptance in an area with no approved treatments and could influence how investors view Belite Bio’s transition from a clinical-stage developer toward a...

Recently, Fabrinet highlighted how it is benefiting from rising automation and AI demand as a manufacturing partner for advanced optical transceivers, high-performance computing clusters, and industrial lasers, underpinned by a debt-free balance sheet. An interesting aspect is Fabrinet’s positioning as a preferred contract manufacturer for leading hyperscalers and networking companies, which could enhance its role across both optical and non-optical communications markets. Next, we’ll...

CoreCivic (CXW) is back in focus after a recent federal funding bill and potential new ICE contracts highlighted possible increases in detention demand, while ongoing asset sale discussions raise questions about future liquidity and capital deployment. See our latest analysis for CoreCivic. At a latest share price of $27.10, CoreCivic has seen strong positive momentum, with a 30-day share price return of 30.67% and a 1-year total shareholder return of 31.49%, as investors react to the funding...

Zenas BioPharma recently reported additional positive Phase 3 INDIGO data for its autoimmune drug obexelimab in Immunoglobulin G4-Related Disease at the 2026 EULAR Congress, alongside publication in the New England Journal of Medicine and submission of a Biologics License Application to the FDA. The trial showed clinically meaningful reductions in disease flares and glucocorticoid toxicity, with a safety profile comparable to placebo, strengthening obexelimab’s profile as a potential...

Interactive Brokers Group (IBKR) has been in focus after rolling out AI powered agentic trading through a direct integration with Claude, alongside presenting at the Morgan Stanley US Financials Conference 2026 in New York. See our latest analysis for Interactive Brokers Group. The recent AI rollout and high profile conference appearance come on top of strong momentum, with a 90 day share price return of 33.0% and year to date share price return of 35.07%, while the 1 year total shareholder...

Event puts Pitolisant program and stock in the spotlight Harmony Biosciences Holdings (HRMY) is drawing fresh attention after six Pitolisant related abstracts were accepted for SLEEP 2026, along with reaffirmed revenue guidance and updated timelines for key regulatory and clinical milestones. See our latest analysis for Harmony Biosciences Holdings. The recent Pitolisant updates and reaffirmed outlook come as the stock trades at US$34.46, with a 30 day share price return of 14.52% and a 1...

Earlier this week, Lincoln Electric Holdings was highlighted as trading at a premium to some intrinsic value estimates despite strong financial health metrics and profitability scores. Investors are increasingly questioning the company’s weak organic revenue growth and declining return on invested capital, raising concerns about the sustainability of its current valuation. We’ll now examine how worries about overvaluation and sluggish organic growth might reshape Lincoln Electric’s...